Physician

Ruchita D Amin, M.D.

According to 2025 Medicare claims, Ruchita Amin, M.D. (NPI: 1235367467) practices ophthalmology in the Lake County-Porter County-Jasper County, IN market, with the plurality of this provider's patient population coming from Lake, IN. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PC (NPI: 1245233014; TIN: 351723470) and primary practice location at 46360-4535.

Amin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 884 traditional Medicare patients, billed 60,771 HCPCS/CPT codes, and received $2,308,177 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 185 prescription claims across 62 beneficiaries totaling $6,604 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,078,396 to $2,308,177. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,387 and ending at $6,604. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.3M2015 Medicare payment: $1,078,396 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,171,169 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,253,275 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,134,838 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,794,322 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,982,211 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,586,973 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,813,866 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,124,857 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,308,177 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157717,983$1,078,396
20168458,985$1,171,169
20171,01011,645$1,253,275
20181,04213,944$2,134,838
201996910,887$1,794,322
202088311,182$1,982,211
20218208,842$1,586,973
202284810,341$1,813,866
202387933,898$2,124,857
202488460,771$2,308,177

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.9K$7.9K2015 Drug cost: $7,387 (USD; Tot_Drug_Cst)2016 Drug cost: $5,890 (USD; Tot_Drug_Cst)2017 Drug cost: $7,208 (USD; Tot_Drug_Cst)2018 Drug cost: $7,715 (USD; Tot_Drug_Cst)2019 Drug cost: $4,623 (USD; Tot_Drug_Cst)2020 Drug cost: $5,113 (USD; Tot_Drug_Cst)2021 Drug cost: $7,191 (USD; Tot_Drug_Cst)2022 Drug cost: $7,881 (USD; Tot_Drug_Cst)2023 Drug cost: $5,875 (USD; Tot_Drug_Cst)2024 Drug cost: $6,604 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201542100$7,387
20163792$5,890
201747115$7,208
201843140$7,715
20193670$4,623
202041108$5,113
202143150$7,191
202251162$7,881
202348128$5,875
202462185$6,604

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye531541$113
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7812,142$84
67028Injection of drug into eye3191,384$82
92134Imaging of retina7932,157$27
92202Extended exam of the back part of the eye with optic nerve drawing8101,752$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate631,942$2,451
Ketorolac TromethamineKetorolac Tromethamine33944$1,182
LatanoprostLatanoprost13700$163
OfloxacinOfloxacin13310$151
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat13830$134

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$121Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ruchita D. Amin, M.D.?

Tedicare shows public-source Medicare data for Ruchita D. Amin, M.D. (NPI 1235367467), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ruchita D. Amin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ruchita D. Amin, M.D.?

Ruchita D. Amin, M.D. is linked to RETINA ASSOCIATES, PC (billing NPI 1245233014) in the available physician profile data.

Does Ruchita D. Amin, M.D. have Open Payments data?

Ruchita D. Amin, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.